Monopar Therapeutics stock closes near session high as buyers regain control

Monopar Therapeutics stock closes near session high as buyers regain control
Monopar Therapeutics gains 3.35% today

Monopar Therapeutics (MNPR) stock is trading at $111.85 after a 3.35% daily gain, ending close to the session high. The price is currently below its short-term averages but remains above key medium- and long-term levels.

MNPR price prediction
24H -0.64%
$70.345
48H 0.73%
$71.31
7D 0.71%
$71.2975
1M 2.15%
$72.3175
3M -20%
$56.6381
6M -32.64%
$47.6849
12M -5.49%
$66.9086
Current price: $70.795 -1.1750 1.63%
Closed 11/17
Daily range 69.3800 Arrow from to Icon 72.3200
Weekly range 67.2200 Arrow from to Icon 74.9100
Loading...

Highlights

  • MNPR/USD exhibits short-term indecision but maintains positive momentum on both medium- and long-term timeframes.
  • A wide trading range between $106.6081 and $119.64 is expected over the next 2–3 sessions.
  • Momentum signals are mixed with overbought conditions and moderate upward probability, but intraday strength lacks confirmation across all indicators.

Mixed intraday signals as momentum and trend diverge

On the hourly chart, MNPR trades below the MA-20 yet stays above the MA-50, while on the daily timeframe it holds well above the MA-200. The Ichimoku Kijun on the daily chart establishes immediate support at $110.86. Among momentum indicators, MACD signals Strong Buy and the Awesome Oscillator remains supportive, but the ADX reflects neutral trend strength. RSI prints a Buy, whereas Stochastic RSI suggests a potential pullback and CCI sits at Neutral. Bull/Bear Power is overbought, highlighting buyer dominance. There is a divergence between some momentum and oscillator readings, pointing to mixed intraday signals despite evident buying strength.

Monopar Therapeutics asset chart
Monopar Therapeutics price dynamics. Source: TradingView.

Sideways consolidation likely as volatility shapes outlook

Over the next 2–3 trading days, the price is forecasted to fluctuate within the $106.61 to $119.64 volatility band. A continuation higher carries a 57% probability, with further upside likely if resistance is decisively breached. Alternatively, a move below support could expose the lower end of the projected range, which is assigned a 43% probability. The baseline scenario sees price consolidating within this broad sideways range as volatility persists.

Anton Kharitonov, analyst at Traders Union, sees mixed signals for MNPR as technical momentum remains strong despite a lack of news drivers. He notes that the price sits above key medium- and long-term averages, but momentum oscillators diverge and intraday direction is unclear. The base scenario is continued consolidation within the $106.61 to $119.64 range. "Until we see a clear break above resistance or below support, I remain neutral and cautious on MNPR’s short-term outlook."

Earlier, analysts noted that Monopar Therapeutics was exhibiting underlying bullish momentum supported by resilient technical structure, despite volatile intraday price action. The latest mixed momentum signals and continued buying interest suggest that traders should closely monitor for a decisive break above or below the $110.86 Kijun support, as this is likely to set the tone for the next phase in price direction.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.